Risk of Seizures in Children Receiving Busulphan-Containing Regimens for Stem Cell Transplantation-Reference-Cited by-同舟云学术

Risk of Seizures in Children Receiving Busulphan-Containing Regimens for Stem Cell Transplantation

Published:2014-02 Issue:2 Volume:20 Page:282-285
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Caselli Désirée,Rosati Anna,Faraci Maura,Podda Marta,Ripaldi Mimmo,Longoni Daniela,Cesaro Simone,Lo Nigro Luca,Paolicchi Olivia,Maximova Natasha,Menconi Maria Cristina,Ziino Ottavio,Cicalese Maria Pia,Santarone Stella,Nesi Francesca,Aricò Maurizio,Locatelli Franco,Prete Arcangelo

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference30 articles.

1. Myleran in chronic myeloid leukaemia; chemical constitution and biological action;Haddow;Lancet,1953

2. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide;Santos;N Engl J Med,1983

3. Busulfan in hematopoietic stem cell transplantation;Ciurea;Biol Blood Marrow Transplant,2009

4. Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313;Pulsipher;Blood,2009

5. Pharmacokinetics of high-dose busulfan in children;Vassal;Cancer Chemother Pharmacol,1989

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epilepsy after acute central nervous system complications of pediatric hematopoietic cell transplantation: A retrospective, multicenter study;Seizure: European Journal of Epilepsy;2024-10

2. Impact of prophylactic echinocandin on the development of neurological complications in patients receiving busulfan‐containing conditioning regimens for stem cell transplantation: A single‐center retrospective study;Pediatric Transplantation;2024-04-10

3. Miscellaneous Complications of Hematopoietic Cellular Transplantation;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

4. Plasma ubiquitin C-terminal hydrolase-L1 (UCH-L1) level as a blood biomarker of neurological damage after allogeneic hematopoietic cell transplantation;International Journal of Hematology;2023-07-22

5. An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse model;EMBO Molecular Medicine;2023-03-06